CN Stock MarketDetailed Quotes
605507 Guobang Pharma Ltd.
- 20.53
- +0.05+0.24%
Market Closed Dec 20 15:00 CST
11.47BMarket Cap16.33P/E (TTM)
20.62High20.40Low16.19KlotVolume20.52Open20.48Pre Close33.19MTurnover0.54%Turnover Ratio18.73P/E (Static)558.82MShares23.0952wk High1.46P/B6.19BFloat Cap12.7152wk Low22.53Limit Up301.72MShs Float46.30Historical High18.43Limit Down1.07%Amplitude12.71Historical Low0.30Dividend TTM20.50Avg Price8.70KlotAsk1.47%Div YieldTTM100Lot Size7.03KlotBid
Guobang Pharma Ltd. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 15.48%3.23B | 10.75%2.08B | 3.41%996.25M | 2.84%2.91B | 4.91%2.79B | 11.75%1.88B | 38.65%963.37M | 5.11%2.83B | 59.36%2.66B | 60.28%1.68B |
| Refunds of taxes and levies | -47.91%121.83M | -59.27%68.72M | -30.89%46.64M | -0.43%200.02M | 32.05%233.9M | 40.61%168.69M | 16.70%67.5M | 47.16%200.88M | 75.33%177.13M | 80.08%119.98M |
| Cash received relating to other operating activities | -32.60%53.36M | -19.05%45.28M | -37.67%16.06M | 35.24%72.47M | 38.14%79.17M | 58.97%55.94M | 149.50%25.77M | 17.93%53.59M | 108.20%57.31M | 80.51%35.19M |
| Cash inflows from operating activities | 9.48%3.4B | 4.34%2.19B | 0.22%1.06B | 3.19%3.18B | 7.23%3.11B | 14.54%2.1B | 38.49%1.06B | 7.31%3.08B | 61.00%2.9B | 61.79%1.84B |
| Goods services cash paid | 10.92%2.6B | 24.12%1.9B | 45.36%865.77M | 65.95%1.71B | 50.99%2.34B | 37.75%1.53B | 28.66%595.59M | -52.80%1.03B | 32.69%1.55B | 144.96%1.11B |
| Staff behalf paid | 6.93%453.44M | 0.24%298.48M | 5.84%181.77M | 14.95%579.97M | 12.91%424.05M | 12.58%297.75M | 12.27%171.74M | 18.48%504.55M | 13.68%375.57M | 16.31%264.48M |
| All taxes paid | 13.91%138.71M | -2.83%98.71M | 19.68%50.68M | -57.34%99.17M | -36.31%121.78M | -10.80%101.59M | -7.49%42.35M | 34.05%232.49M | 20.85%191.19M | -9.02%113.89M |
| Cash paid relating to other operating activities | -14.50%175.35M | 4.24%145.16M | 8.97%39.86M | -8.46%270.05M | 23.97%205.08M | 2.93%139.25M | 11.57%36.58M | 13.38%294.99M | -13.34%165.43M | 15.13%135.28M |
| Cash outflows from operating activities | 8.81%3.37B | 18.02%2.44B | 34.48%1.14B | 28.98%2.66B | 35.47%3.1B | 27.36%2.07B | 21.86%846.26M | -32.25%2.07B | 23.53%2.28B | 75.93%1.63B |
| Net cash flows from operating activities | 201.75%32.88M | -881.67%-249.98M | -137.61%-79.11M | -49.19%516.76M | -98.22%10.9M | -84.76%31.98M | 207.00%210.38M | 677.26%1.02B | 1,311.84%611.76M | -0.30%209.91M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -1.69%1.33B | -65.29%345M | -65.65%192.21M | -61.78%1.35B | -57.32%1.35B | -51.71%993.96M | -51.34%559.63M | 92.00%3.53B | 166.33%3.17B | 5,144.66%2.06B |
| Cash received from returns on investments | -92.21%1.41M | -85.24%992.49K | -76.02%992.49K | ---- | -11.05%18.11M | -49.36%6.72M | -66.27%4.14M | -99.99%393.73 | --20.36M | --13.28M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | 39.79%24.9M | ---- | ---- | ---- | 310.72%17.81M | -99.46%29.21K | -97.89%29.21K |
| Cash inflows from investing activities | -2.89%1.33B | -65.42%345.99M | -65.73%193.2M | -61.27%1.37B | -57.03%1.37B | -51.70%1B | -51.50%563.77M | 91.93%3.55B | 166.82%3.19B | 4,999.02%2.07B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -57.11%204.27M | -49.57%171.92M | -17.20%126.93M | -6.81%748.44M | 19.85%476.26M | 50.43%340.92M | 109.73%153.31M | 79.25%803.12M | 6.05%397.38M | -17.64%226.63M |
| Cash paid to acquire investments | 89.19%1.53B | -29.56%389.47M | -82.32%61.88M | -68.73%987.48M | -71.92%808.43M | -66.79%552.9M | -68.61%350.01M | 2.16%3.16B | 25.80%2.88B | 4,165.43%1.67B |
| Cash outflows from investing activities | 34.95%1.73B | -37.19%561.39M | -62.49%188.81M | -56.17%1.74B | -60.80%1.28B | -52.75%893.83M | -57.64%503.32M | 11.92%3.96B | 23.02%3.28B | 502.02%1.89B |
| Net cash flows from investing activities | -559.20%-401.26M | -301.57%-215.4M | -92.75%4.38M | 12.22%-361.47M | 203.84%87.38M | -40.63%106.86M | 335.46%60.44M | 75.63%-411.76M | 94.26%-84.15M | 165.79%180M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --580K | --580K | --530K | 15,085.19%8.2M | ---- | ---- | ---- | -100.00%54K | -100.00%54K | --54K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --580K | --580K | --530K | 15,085.19%8.2M | ---- | ---- | ---- | --54K | --54K | ---- |
| Cash from borrowing | -7.12%672.45M | -23.11%488M | 118.28%203M | 23.89%964M | 11.08%724M | 24.02%634.7M | 9.41%93M | 113.51%778.11M | 151.22%651.78M | 97.16%511.78M |
| Cash received relating to other financing activities | --97.11M | ---- | ---- | 0.00%1M | ---- | ---- | ---- | --1M | -70.61%705.37K | ---- |
| Cash inflows from financing activities | 6.37%770.14M | -23.02%488.58M | 118.85%203.53M | 24.90%973.2M | 10.95%724M | 24.00%634.7M | 9.41%93M | -74.38%779.16M | -77.79%652.54M | 95.37%511.84M |
| Borrowing repayment | 17.76%632.13M | -11.63%375.8M | --94.5M | 131.98%656.5M | 854.35%536.81M | 655.99%425.24M | ---- | -74.61%283M | -93.98%56.25M | -87.21%56.25M |
| Dividend interest payment | -46.50%188.04M | -47.37%181.67M | 40.70%7.33M | 182.06%361.64M | 188.26%351.5M | 195.64%345.2M | 187.58%5.21M | -61.58%128.21M | 150.82%121.94M | 146.20%116.76M |
| Cash payments relating to other financing activities | --101.01M | --99.53M | --27.59M | 0.00%1M | ---- | ---- | ---- | -95.49%1M | -90.87%2.24M | ---- |
| Cash outflows from financing activities | 3.70%921.18M | -14.72%656.99M | 2,384.71%129.42M | 147.24%1.02B | 392.34%888.31M | 345.31%770.44M | -90.83%5.21M | -71.97%412.21M | -82.10%180.43M | -64.81%173.01M |
| Net cash flows from financing activities | 8.08%-151.04M | -24.07%-168.41M | -15.58%74.11M | -112.52%-45.94M | -134.80%-164.31M | -140.06%-135.74M | 211.44%87.79M | -76.63%366.95M | -75.55%472.11M | 247.53%338.82M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 74.71%14.13M | 293.40%16.46M | 215.49%6.14M | -69.65%10.71M | -82.94%8.09M | -81.43%4.18M | -576.67%-5.32M | 455.09%35.27M | 1,294.66%47.4M | 594.05%22.52M |
| Net increase in cash and cash equivalents | -771.99%-505.29M | -8,575.09%-617.34M | -98.44%5.52M | -88.08%120.07M | -105.53%-57.95M | -99.03%7.28M | 402.83%353.3M | 429.86%1.01B | 155.94%1.05B | 352.73%751.26M |
| Add:Begin period cash and cash equivalents | 7.59%1.7B | 7.59%1.7B | 7.59%1.7B | 175.62%1.58B | 175.62%1.58B | 175.62%1.58B | 175.62%1.58B | -34.74%573.67M | -34.74%573.67M | -34.74%573.67M |
| End period cash equivalent | -21.49%1.2B | -31.76%1.08B | -11.77%1.71B | 7.59%1.7B | -6.02%1.52B | 19.89%1.59B | 200.41%1.93B | 175.62%1.58B | 25.82%1.62B | 127.71%1.32B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
